Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Financings In Brief

This article was originally published in The Gray Sheet

Executive Summary

Dehaier Medical Systems goes public: Developer of medical devices for the Chinese market goes public through a $12 million offering of 1.5 million shares at $8 each, completed April 22. The firm assembles branded products at its Beijing facility from components made by third parties, and also distributes finished products made by other companies. Offerings include x-ray, anesthesia and patient monitoring systems, as well as home respiratory and oxygen products. Proceeds from the initial public offering are tabbed for R&D, marketing, potential acquisitions and working capital. The shares trade on the Nasdaq exchange under the symbol "DHRM." Anderson & Strudwick was placement agent for the offering

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028821

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel